👉 Futuristic Sector : Bio Technology
🌟 Every Smart Investors Should Be of 11 Stocks From the Sector✨
👉 A Thread 🧵👇...
#StocksToWatch #StockMarket #investing #investments #StocksToWatch #biotechnology
🌟 Every Smart Investors Should Be of 11 Stocks From the Sector✨
👉 A Thread 🧵👇...
#StocksToWatch #StockMarket #investing #investments #StocksToWatch #biotechnology
1 Biocon Ltd Business model
Biocon is engaged in the business of manufacture of biotechnology products and research services.
Biocon is engaged in the business of manufacture of biotechnology products and research services.
👉Key ratios
⚡Market Cap : ₹ 36,786 Cr.
⚡Current Price : ₹ 306
⚡Stock P/E : 30.7
⚡ROCE : 5.92 %
⚡ROE : 4.78 %
⚡Debt to equity : 0.96
⚡Profit Var 3Yrs : -3.48 %
⚡Sales growth 3Years : 21.0 %
⚡Market Cap : ₹ 36,786 Cr.
⚡Current Price : ₹ 306
⚡Stock P/E : 30.7
⚡ROCE : 5.92 %
⚡ROE : 4.78 %
⚡Debt to equity : 0.96
⚡Profit Var 3Yrs : -3.48 %
⚡Sales growth 3Years : 21.0 %
2 Concord Biotech ltd Business model
Concord Biotech Limited is an India-based R&D-driven biopharma company
Concord Biotech Limited is an India-based R&D-driven biopharma company
👉Key ratios
⚡Market Cap : ₹ 17,367 Cr.
⚡Current Price : ₹ 1,660
⚡Stock P/E : 57.7
⚡ROCE : 26.2 %
⚡ROE : 19.6 %
⚡Debt to equity : 0.02
⚡Profit Var 3Yrs : 15.8 %
⚡Sales growth 3Years : 18.5 %
⚡Market Cap : ₹ 17,367 Cr.
⚡Current Price : ₹ 1,660
⚡Stock P/E : 57.7
⚡ROCE : 26.2 %
⚡ROE : 19.6 %
⚡Debt to equity : 0.02
⚡Profit Var 3Yrs : 15.8 %
⚡Sales growth 3Years : 18.5 %
3 sun pharma Advanced research company ltd business model
Sun Pharma Advanced Research Company Ltd is engaged in the business of research and development
Sun Pharma Advanced Research Company Ltd is engaged in the business of research and development
👉Key ratios
⚡Market Cap : ₹ 8,352 Cr.
⚡Current Price : ₹ 257
⚡ROCE : -106 %
⚡ROE : -144 %
⚡Debt to equity : 0.04
⚡Profit Var 3Yrs : 9.19 %
⚡Sales growth 3Years : 46.0 %
⚡Market Cap : ₹ 8,352 Cr.
⚡Current Price : ₹ 257
⚡ROCE : -106 %
⚡ROE : -144 %
⚡Debt to equity : 0.04
⚡Profit Var 3Yrs : 9.19 %
⚡Sales growth 3Years : 46.0 %
4 Windlas Biotech ltd business model
It is a leading domestic pharmaceutical formulations contract development and manufacturing organization
It is a leading domestic pharmaceutical formulations contract development and manufacturing organization
👉Key ratios
⚡Market Cap : ₹ 1,138 Cr.
⚡Current Price : ₹ 547
⚡Stock P/E : 21.6
⚡ROCE : 14.1 %
⚡ROE : 10.5 %
⚡Debt to equity : 0.02
⚡Profit Var 3Yrs : 37.3 %
⚡Sales growth 3Years : 16.0 %
⚡Market Cap : ₹ 1,138 Cr.
⚡Current Price : ₹ 547
⚡Stock P/E : 21.6
⚡ROCE : 14.1 %
⚡ROE : 10.5 %
⚡Debt to equity : 0.02
⚡Profit Var 3Yrs : 37.3 %
⚡Sales growth 3Years : 16.0 %
5 Vivo biotech Ltd Business model
Vivo Bio Tech Ltd is a supplier of SPF lab animals and is a breeder
& distributor of rodent models.
Vivo Bio Tech Ltd is a supplier of SPF lab animals and is a breeder
& distributor of rodent models.
👉Key ratios
⚡Market Cap : ₹ 67.2 Cr.
⚡Current Price : ₹ 45.1
⚡Stock P/E : 17.4
⚡ROCE : 11.0 %
⚡ROE : 5.39 %
⚡Debt to equity : 1.20
⚡Profit Var 3Yrs : -15.8 %
⚡Sales growth 3Years : -1.92 %
⚡Market Cap : ₹ 67.2 Cr.
⚡Current Price : ₹ 45.1
⚡Stock P/E : 17.4
⚡ROCE : 11.0 %
⚡ROE : 5.39 %
⚡Debt to equity : 1.20
⚡Profit Var 3Yrs : -15.8 %
⚡Sales growth 3Years : -1.92 %
6 Syngene international business model
It is an integrated service provider offering end-to-end drug discovery, development, and manufacturing services on a single platform
It is an integrated service provider offering end-to-end drug discovery, development, and manufacturing services on a single platform
👉key ratios
⚡Market Cap : ₹ 28,121 Cr.
⚡Current Price : ₹ 699
⚡Stock P/E : 54.2
⚡ROCE : 14.7 %
⚡ROE : 13.2 %
⚡Debt to equity : 0.13
⚡Profit Var 3Yrs : 11.0 %
⚡Sales growth 3Years : 16.9 %
⚡Market Cap : ₹ 28,121 Cr.
⚡Current Price : ₹ 699
⚡Stock P/E : 54.2
⚡ROCE : 14.7 %
⚡ROE : 13.2 %
⚡Debt to equity : 0.13
⚡Profit Var 3Yrs : 11.0 %
⚡Sales growth 3Years : 16.9 %
7 ANG LIFESCIENCE india ltd Business model
It manufactures and markets finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials
It manufactures and markets finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials
👉Key ratios
⚡Market Cap : ₹ 74.7 Cr.
⚡Current Price : ₹ 57.2
⚡ROCE : 8.51 %
⚡ROE : -0.46 %
⚡Debt to equity : 0.68
⚡Sales growth 3Years : 17.9 %
⚡Market Cap : ₹ 74.7 Cr.
⚡Current Price : ₹ 57.2
⚡ROCE : 8.51 %
⚡ROE : -0.46 %
⚡Debt to equity : 0.68
⚡Sales growth 3Years : 17.9 %
8 Genomic valley biotech Ltd Business model
Genomic Valley Biotech Ltd is engaged in Horticulture business
Genomic Valley Biotech Ltd is engaged in Horticulture business
👉Key ratios
⚡Market Cap : ₹ 8.89 Cr.
⚡Current Price : ₹ 29.1
⚡Stock P/E : 8.72
⚡ROCE : 28.5 %
⚡ROE : 28.5 %
⚡Debt to equity : 0.00
⚡Sales growth 3Years : 47.4 %
⚡Profit Var 3Yrs : 46.4 %
⚡Market Cap : ₹ 8.89 Cr.
⚡Current Price : ₹ 29.1
⚡Stock P/E : 8.72
⚡ROCE : 28.5 %
⚡ROE : 28.5 %
⚡Debt to equity : 0.00
⚡Sales growth 3Years : 47.4 %
⚡Profit Var 3Yrs : 46.4 %
9 Wockhardt Ltd Business model
Wockhardt is a global pharmaceutical and biotechnology organization engaged in manufacturing finished dosage formulations, injectables
Wockhardt is a global pharmaceutical and biotechnology organization engaged in manufacturing finished dosage formulations, injectables
👉Key ratios
⚡Market Cap : ₹ 8,801 Cr.
⚡Current Price : ₹ 574
⚡ROCE : -0.46 %
⚡ROE : -8.31 %
⚡Debt to equity : 0.73
⚡Sales growth 3Years : -2.32 %
⚡Market Cap : ₹ 8,801 Cr.
⚡Current Price : ₹ 574
⚡ROCE : -0.46 %
⚡ROE : -8.31 %
⚡Debt to equity : 0.73
⚡Sales growth 3Years : -2.32 %
10 Dr Reddy's laboratories Ltd Business model
Dr. Reddy's Laboratories Ltd is a leading India-based pharamceutical company which offers a portfolio of products
Dr. Reddy's Laboratories Ltd is a leading India-based pharamceutical company which offers a portfolio of products
👉Key ratios
⚡Market Cap : ₹ 1,04,296 Cr.
⚡Current Price : ₹ 6,252
⚡Stock P/E : 20.0
⚡ROCE : 26.7 %
⚡ROE : 21.6 %
⚡Debt to equity : 0.05
⚡Sales growth 3Years : 12.1 %
⚡Profit Var 3Yrs : 31.3 %
⚡Market Cap : ₹ 1,04,296 Cr.
⚡Current Price : ₹ 6,252
⚡Stock P/E : 20.0
⚡ROCE : 26.7 %
⚡ROE : 21.6 %
⚡Debt to equity : 0.05
⚡Sales growth 3Years : 12.1 %
⚡Profit Var 3Yrs : 31.3 %
11 Panacea Biotech Ltd Business model
Panacea Biotec is a research based Biotechnology company
Panacea Biotec is a research based Biotechnology company
👉Key ratios
⚡Market Cap : ₹ 880 Cr.
⚡Current Price : ₹ 144
⚡ROCE : -10.3 %
⚡ROE : -10.9 %
⚡Debt to equity : 0.02
⚡Sales growth 3Years : -5.44 %
⚡Profit Var 3Yrs : 12.2 %
⚡Market Cap : ₹ 880 Cr.
⚡Current Price : ₹ 144
⚡ROCE : -10.3 %
⚡ROE : -10.9 %
⚡Debt to equity : 0.02
⚡Sales growth 3Years : -5.44 %
⚡Profit Var 3Yrs : 12.2 %
Visit our telegram channel👇
t.me
t.me
The content in this post is only for educational purpose and not investment advice. Please consult your financial advisors before investing.
Loading suggestions...